5752175
Last Update Posted: 2024-06-12
Recruiting has ended
All Genders accepted | 18 Years + |
80 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection
A randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of WPV01 in patients with mild/moderate COVID-19 infection
Eligibility
Relevant conditions:
COVID-19 Infection
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Data sourced from ClinicalTrials.gov